For the Inventor, By the Inventor

Enter assignee name

Brisbane, CA, United States of America

Cellegy Pharmaceuticals Inc.

USPTO Granted Patents = 19

% Expired Patents = 36.8

Forward Citations = 614

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Stephen Grayson (7 out of 7 patents)

Carl R Thornfeldt (7 out of 19 patents)

Thomas P Parks (4 out of 9 patents)

4. Vivien H W Mak (4 out of 5 patents)

5. Peter Michael Elias (4 out of 18 patents)

6. Michael A Adams (3 out of 26 patents)

7. Jeremy P W Heaton (3 out of 19 patents)

8. Charles E Lee (3 out of 6 patents)

9. Jung-Chung Lee (3 out of 9 patents)

10. Don R Baker (2 out of 137 patents)

11. Vivien Mak (2 out of 3 patents)

12. Lynne-Marie Postovit (1 out of 5 patents)

13. Charles H Graham (1 out of 4 patents)

14. Donald H Maurice (1 out of 1 patent)

15. Kenneth R Feingold (1 out of 8 patents)

19 patents: Sort by Forward Citations

1. 7157097 - Penetration enhancing and irritation reducing systems (2007-01-02),

2. 6987129 - Compounds and methods for the treatment of urogenital disorders (2006-01-17),

3. 6946484 - Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype (2005-09-20),

4. 6889875 - Taper well meter dose pump (2005-05-10),

5. 6869961 - Store operated calcium influx inhibitors and methods of use (2005-03-22),

6. 6787553 - Methods for remodeling neuronal and cardiovascular pathways (2004-09-07),

7. 6747063 - Combination therapy for treatment of erectile dysfunction (2004-06-08),

8. 6699886 - Store operated calcium influx inhibitors and methods of use (2004-03-02),

9. 6627632 - Compositions and methods for the treatment of anorectal disorders (2003-09-30),

10. 6579865 - Penetration enhancing and irritation reducing systems (2003-06-17),

11. 6482839 - Pyridine-thiols for treatment of a follicular dermatosis (2002-11-19),

12. 6395736 - Compositions and methods for the treatment of anorectal disorders (2002-05-28),

13. 6319913 - Penetration enhancing and irritation reducing systems (2001-11-20),

14. 6071543 - Pyridine-thiols reverse mucocutaneous aging (2000-06-06),

15. 6010691 - Methods for enhancing permeation of a topically administered (2000-01-04),

Cellegy Pharmaceuticals Inc. is a biopharmaceutical company based in Brisbane, California, focused on developing innovative therapies for various medical conditions. The company specializes in drug delivery systems and formulations, particularly in the fields of dermatology and urology. Cellegy is dedicated to advancing its proprietary technologies to enhance patient outcomes and improve treatment efficacy. Through its research initiatives, the company aims to address unmet medical needs and contribute to the evolving landscape of pharmaceutical solutions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

19 Patents

#7 in Brisbane, CA

#4,095 in California

#17,123 in US

#32,623 in the World

Brisbane, CA, United States of America

Cellegy Pharmaceuticals Inc.

Forward Citations = 614

15 inventors:

Stephen Grayson (7 out of 7 patents)

Carl R Thornfeldt (7 out of 19 patents)

Thomas P Parks (4 out of 9 patents)

4. Vivien H W Mak (4 out of 5 patents)

5. Peter Michael Elias (4 out of 18 patents)

Please report any incorrect information to [email protected]

Loading…